We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH
RNS Number : 1418D
Dechra Pharmaceuticals PLC
24 April 2017
24 April 2017
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
In accordance with article 19(1) of the Market Abuse Regulations, the Company was notified today that due to a change in personal circumstances Ian Page's total beneficial interest in the Company is now 811,308 shares, which represents 0.871% of the current issued share capital.
The reduction in his beneficial shareholding relates to shares held by his sons, Andrew, David and Michael Page, who are no longer classified as a connected person under the Market Abuse Regulations.
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") --- -------------------------------------------------------------- a) Name Ian Page --- ----------------------------- ------------------------------- 2. Reason for the notification --- -------------------------------------------------------------- a) Position/status Director --- ----------------------------- ------------------------------- b) Initial notification/ Initial Notification amendment --- ----------------------------- ------------------------------- 3. Details of the Issuer --- -------------------------------------------------------------- a) Name Dechra Pharmaceuticals PLC --- ----------------------------- ------------------------------- b) LEI code N/A --- ----------------------------- ------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- -------------------------------------------------------------- a) Description Ordinary Shares of 1 pence of the financial each instrument Identification ISIN: GB0009633180 code --- ----------------------------- ------------------------------- b) Nature of Shares held by sons, who are the transaction no longer connected people --- ----------------------------- ------------------------------- c) Price(s) and Price(s) Volume(s) volumes(s) Nil cost 2,600 Nil cost 2,000 Nil cost 2,000 --- ----------------------------- --------------- -------------- d) Aggregated information * Aggregate volume 6,600 Nil cost * Price --- ----------------------------- ------------------------------- e) Date of the 2017.04.24 transaction --- ----------------------------- ------------------------------- f) Place of the Outside a trading venue transaction --- ----------------------------- -------------------------------
For further information, please contact:
Suzana Cross, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKQDBDBKDCQB
(END) Dow Jones Newswires
April 24, 2017 07:30 ET (11:30 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions